These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Serum Vitamin B12 Deficiency in Chronic Hemodialysis Patients. Mushtaq M; Usmani MR; Hameed N; Anwar A; Hashmi AA Cureus; 2024 Apr; 16(4):e58751. PubMed ID: 38779272 [TBL] [Abstract][Full Text] [Related]
5. Influence of dialysis techniques and alternate vitamin supplementation on homocysteine levels in patients with known MTHFR genotypes. Dessì M; Di Giovamberardino G; Pieri M; Noce A; Zenobi R; Di Daniele N; Pastore A Clin Exp Nephrol; 2015 Feb; 19(1):140-5. PubMed ID: 24652221 [TBL] [Abstract][Full Text] [Related]
6. Mesna for treatment of hyperhomocysteinemia in hemodialysis patients: a placebo-controlled, double-blind, randomized trial. Urquhart BL; Freeman DJ; Cutler MJ; Mainra R; Spence JD; House AA Clin J Am Soc Nephrol; 2008 Jul; 3(4):1041-7. PubMed ID: 18337551 [TBL] [Abstract][Full Text] [Related]
7. Homocysteine and renal disease. van Guldener C; Robinson K Semin Thromb Hemost; 2000; 26(3):313-24. PubMed ID: 11011849 [TBL] [Abstract][Full Text] [Related]
8. Therapy of hyperhomocysteinemia in end-stage renal disease patients. Hagen W; Födinger M; Hörl WH; Sunder-Plass-Mann G Minerva Urol Nefrol; 2001 Sep; 53(3):159-70. PubMed ID: 11723441 [TBL] [Abstract][Full Text] [Related]
9. Controlled trials of very high dose folic acid, vitamins B12 and B6, intravenous folinic acid and serine for treatment of hyperhomocysteinemia in ESRD. Gonin JM; Nguyen H; Gonin R; Sarna A; Michels A; Masri-Imad F; Bommareddy G; Chassaing C; Wainer I; Loya A; Cary D; Barker LF; Assefi A; Greenspan R; Mahoney D; Wilcox CS J Nephrol; 2003; 16(4):522-34. PubMed ID: 14696754 [TBL] [Abstract][Full Text] [Related]
10. Parenteral vitamin B12 therapy of hyperhomocysteinemia in end-stage renal disease. Hoffer LJ; Elian KM Clin Invest Med; 2004 Feb; 27(1):10-3. PubMed ID: 15061579 [TBL] [Abstract][Full Text] [Related]
11. Vitamin B12 decreases, but does not normalize, homocysteine and methylmalonic acid in end-stage renal disease: a link with glycine metabolism and possible explanation of hyperhomocysteinemia in end-stage renal disease. Hyndman ME; Manns BJ; Snyder FF; Bridge PJ; Scott-Douglas NW; Fung E; Parsons HG Metabolism; 2003 Feb; 52(2):168-72. PubMed ID: 12601627 [TBL] [Abstract][Full Text] [Related]
12. [The treatment of hyperhomocysteinemia in patients on dialysis: folic acid or the high-flow polysulphonic membrane?]. Lovcić V; Kes P; Zeljko R; Kusec V Acta Med Croatica; 2006 Jun; 60(3):201-8. PubMed ID: 16933832 [TBL] [Abstract][Full Text] [Related]
13. [Efficacy and safety of two vitamin supplement regimens on homocysteine levels in hemodialysis patients. Prospective, randomized clinical trial]. Sánchez Alvarez JE; Pérez Tamajón L; Hernández D; Alvarez González A; Delgado P; Lorenzo V Nefrologia; 2005; 25(3):288-96. PubMed ID: 16053010 [TBL] [Abstract][Full Text] [Related]